Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reactive oxygen species (ROS) generation machinery encompasses a collection of enzymes and organelles that produce pro-oxidant molecules, primarily superoxide and hydrogen peroxide. Key components include the NADPH oxidase (NOX) family (NOX1-5, DUOX1-2), the mitochondrial electron transport chain (specifically Complexes I and III), xanthine oxidase, and cytochrome P450 enzymes (Bedard & Krause, 2007; Murphy, 2009). Under physiological conditions, these systems generate ROS that act as vital signaling molecules for cell growth, differentiation, and the immune response (Lambeth, 2004). However, dysregulation of this machinery leads to excessive ROS production, resulting in oxidative stress and damage to cellular macromolecules, which is a hallmark of diseases such as atherosclerosis, hypertension, neurodegeneration, and cancer (Brand, 2016). Therapeutic strategies target specific elements of this machinery, such as NOX inhibitors (e.g., Setanaxib) or xanthine oxidase inhibitors (e.g., Allopurinol), to mitigate oxidative damage. A significant challenge in targeting this machinery is the need to selectively inhibit pathological ROS production without interfering with essential redox-mediated signaling pathways required for normal cellular function.
Inhibition of NADPH oxidase (NOX) enzymes, inhibition of xanthine oxidase, or modulation of mitochondrial electron transport chain complexes to reduce the production of superoxide and hydrogen peroxide.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation machinery (ROS generation machinery).